Concepedia

Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients

Bastien Misgault, Eva Chatron, Quitterie Reynaud, Sandrine Touzet, Michel Abély, Laurent Melly, S. Dominique, Françoise Troussier, Olivia Ronsin-Pradel, M. Gérardin,

Journal of Cystic Fibrosis · 2020 · 67 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>

Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

, , +15

Factors associated with FEV<sub>1</sub>decline in cystic fibrosis: analysis of the ECFS Patient Registry

Eitan Kerem, Laura Viviani, Anna Zolin et al. · European Respiratory Journal · 2013 · 296 citations · Full text

, , +16

Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study

Melena D. Bellin, Theresa A. Laguna, Janice Leschyshyn et al. · Pediatric Diabetes · 2013 · 193 citations

, , +17

Cystic fibrosis–related diabetes is caused by islet loss and inflammation

Nathaniel Hart, Radhika Aramandla, Gregory Poffenberger et al. · JCI Insight · 2018 · 184 citations · Full text

, , +17

Glucose-induced electrical activities and insulin secretion in pancreatic islet β-cells are modulated by CFTR

Hui Chen, Ye Chun Ruan, Xue Lian Zhang et al. · Nature Communications · 2014 · 154 citations · Full text

, , +17